Evaluation of Osseous Metastasis in Bone Scintigraphy

被引:67
作者
Davila, Diego [1 ]
Antoniou, Alexander [2 ]
Chaudhry, Muhammad A. [1 ,2 ]
机构
[1] Johns Hopkins Univ, Russel H Morgan Dept Radiol & Radiol Sci, Baltimore, MD 21287 USA
[2] Tawam Mol Imaging Ctr, Al Ain, U Arab Emirates
关键词
POSITRON-EMISSION-TOMOGRAPHY; F-18-FLUORIDE PET; PROSTATE-CANCER; BREAST; SPECT; LUNG; RISK; CT;
D O I
10.1053/j.semnuclmed.2014.07.004
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Bone scintigraphy (BS) is an imaging tool commonly used for screening patients with cancer, especially those with high prevalence of osseous metastases including the breast, prostate, lung, thyroid, and kidney, which account for 80% of osseous metastasis. BS has been shown to be of value in the initial and subsequent treatment strategy of various malignancies. The purpose of this article is to evaluate the technical and imaging aspects of BS and to examine the present research into improved detection of osseous metastasis. (C) 2015 Elsevier Inc. All rights reserved.
引用
收藏
页码:3 / 15
页数:13
相关论文
共 26 条
[1]  
[Anonymous], BONE SCINTIGRAPHY
[2]  
[Anonymous], BON MET
[3]   Meta-analysis: Comparison of F-18 Fluorodeoxyglucose-Positron Emission Tomography and Bone Scintigraphy in the Detection of Bone Metastasis in Patients with Lung Cancer [J].
Chang, Ming-Che ;
Chen, Jin-Hua ;
Liang, Ji-An ;
Lin, Cheng-Chieh ;
Yang, Kuang-Tao ;
Cheng, Kai-Yuan ;
Yeh, Jun-Jun ;
Kao, Chia-Hung .
ACADEMIC RADIOLOGY, 2012, 19 (03) :349-357
[4]  
Chansky HA, METASTATIC CARCINOMA
[5]   Clinical features of metastatic bone disease and risk of skeletal morbidity [J].
Coleman, Robert E. .
CLINICAL CANCER RESEARCH, 2006, 12 (20) :6243S-6249S
[6]   The role of 18F-fluoride PET-CT in the detection of bone metastases in patients with breast, lung and prostate carcinoma: a comparison with FDG PET/CT and 99mTc-MDP bone scan [J].
Damle, Nishikant Avinash ;
Bal, Chandrasekhar ;
Bandopadhyaya, G. P. ;
Kumar, Lalit ;
Kumar, Praveen ;
Malhotra, Arun ;
Lata, Sneh .
JAPANESE JOURNAL OF RADIOLOGY, 2013, 31 (04) :262-269
[7]  
Even-Sapir E, 2006, J NUCL MED, V47, P287
[8]  
Even-Sapir E, 2005, J NUCL MED, V46, P1356
[9]  
Guidelines and Standards Committee of the ACR Commission on Nuclear Medicine in collaboration with the SPR, 2012, GUID STAND COMM ACR
[10]   Bone imaging in metastatic breast cancer [J].
Hamaoka, T ;
Madewell, JE ;
Podoloff, DA ;
Hortobagyi, GN ;
Ueno, NT .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) :2942-2953